Retrospective study of elderly patients with advanced ovarian cancer who did not undergo surgery
Chemotherapy with or without bevacizumab, followed by PARP inhibitor maintenance therapy, is a viable alternative for elderly or surgically ineligible patients with advanced ovarian cancer. The findings of this study should be considered exploratory and require validation through large-scale studies.
Authors
- Yu Xia (ORCID: https://orcid.org/0000-0002-6397-1205)
- Qingyi Wei (ORCID: https://orcid.org/0000-0002-3845-9445)
- Wen Gu (ORCID: https://orcid.org/0000-0003-1414-0605)
- Zhenhua Du (ORCID: https://orcid.org/0009-0006-6190-6107)
- Xiuqin Li (ORCID: https://orcid.org/0000-0002-9649-605X)
- Hui Qü (ORCID: https://orcid.org/0000-0003-4456-4070)
Institutions
- China Medical University (CN)
Publication Details
- Journal
- The Oncologist
- Published
- 2025-09-18
- DOI
- https://doi.org/10.1093/oncolo/oyaf290
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00